Clinical outcome of pazopanib in Japanese patients with soft tissue sarcoma; Multicenter study
Not Applicable
- Conditions
- Malignant soft tissue tumor
- Registration Number
- JPRN-UMIN000012561
- Lead Sponsor
- Japanese Musculoskeletal Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are not treated in the registered institutions of Japanese Musculoskeletal Oncology Group will be excluded from this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Survival Progressive-free survival Side effect
- Secondary Outcome Measures
Name Time Method